Summary
Chronobiological treatments—including bright light therapy and wake therapy (sleep deprivation)—represent rapid, effective, non-pharmacological interventions for mood disorders, with sleep deprivation capable of improving mood within hours when combined with morning light to sustain effects. Despite strong evidence, these approaches remain underutilized in clinical guidelines due to lack of commercial sponsorship, insurance non-reimbursement, and perception as 'alternative' treatments, suggesting a need for greater integration into standard care protocols.
Key Findings
- Sleep deprivation ('wake therapy') can produce antidepressant effects within hours, with effects maintained by combining regular morning light administration with earlier sleep timing.
- Mood disorders are consistently characterized by circadian rhythm alterations, sleep disturbances, and seasonal exacerbation, implicating the circadian system as a core therapeutic target.
- Chronotherapeutics remain absent from first-line treatment guidelines despite efficacy, primarily due to lack of patentability, absent industry sponsors for large multi-centre trials, and non-reimbursement by insurance.
- Putative neurochemical mechanisms underlying light and sleep therapy antidepressant effects include neurotransmitter switching, stress/cortico-limbic reactivity modulation, clock gene expression, cortical neuroplasticity, and neuroinflammation reduction.
Categories
Mood & Mental Wellness: Reviews chronobiological treatments including light therapy and sleep deprivation as antidepressant interventions for mood disorders.
Sleep & Circadian Health: Examines circadian rhythm disruptions in mood disorders and zeitgeber-based interventions to stabilize sleep and mood.
Seasonal Affective Disorder: Addresses seasonal exacerbation of affective disorders and the role of morning light administration in treatment.
Author(s)
A Wirz‐Justice, F Benedetti
Publication Year
2020
Number of Citations
86
Related Publications
Mood & Mental Wellness
- The two‐process model of sleep regulation: a reappraisal
- Protecting the melatonin rhythm through circadian healthy light exposure
- Effects of artificial dawn and morning blue light on daytime cognitive performance, well-being, cortisol and melatonin levels
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- The role of daylight for humans: gaps in current knowledge
Sleep & Circadian Health
- Phototransduction by retinal ganglion cells that set the circadian clock
- The mammalian circadian timing system: organization and coordination of central and peripheral clocks
- The two‐process model of sleep regulation: a reappraisal
- Melanopsin is required for non-image-forming photic responses in blind mice
- Strange vision: ganglion cells as circadian photoreceptors
Seasonal Affective Disorder
- Lux vs. wavelength in light treatment of Seasonal Affective Disorder
- High prevalence of seasonal affective disorder among persons with severe visual impairment
- A possible role of perinatal light in mood disorders and internal cancers: reconciliation of instability and latitude concepts
- Daily and seasonal variation in light exposure among the Old Order Amish
- The Recent History of Seasonal Affective Disorder (SAD)